Last reviewed · How we verify
NCT03940339
Suboccipitalis Myofascial Release in Hamstring Tightness in Patients With Anterolisthesis
NA trial testing Suboccipital myofascial release in Anterolisthesis in 32 participants. Terminated before completion.
18 March 2020
Quick facts
| Lead sponsor | Asir John Samuel |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 32 |
| Start date | 1 September 2019 |
| Primary completion | 18 March 2020 |
| Estimated completion | 19 March 2020 |
| Sites | 1 location across India |
Drugs / interventions tested
- Suboccipital myofascial release
- Conventional Physiotherapy
Conditions studied
- Anterolisthesis — all drugs for Anterolisthesis →
Sponsor
Asir John Samuel
Who can join
Adults 35 to 55, any sex, with Anterolisthesis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: Anterolisthesis presents with tightness of hamstring muscle which is a major contributing factor for low back pain and disability. Suboccipital Myofascial release decreases the tension in the fascia and helps to amend the muscle imbalance. There is a presence of superficial backline between suboccipitalis and hamstring muscle. Aim: The purpose of the study is to find out the effect of sub occipital myofascial release on hamstring tightness along with pain and disability associated with it in Anterolisthesis. Methods: The study will recruit individuals with Anterolisthesis between the age of 35- 55. Pathologies which will limit or interfere with the test outcome shall be excluded. The samples will be collected using criterion based sampling. Procedure will be explained prior to the intervention Data analysis: Normality of the collected data will be established by Shapiro Wilk Test. Based on the normality, descriptive statistics data will be expressed as mean ± standard deviation or median and intra quartile range. Within group comparison will be done by paired t test or Wilcoxon signed rank test and between group comparison will be done through independent t test or Mann Whitney U test.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03940339
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Asir John Samuel trials
Trials by the same sponsor.
- NCT05160519 — Class IV Laser Therapy on Ejection Fraction, Cardio Biomarkers and Functional Outcomes · NA · unknown
- NCT04084743 — Dual Task and Virtuality Training Innovation to Improve Balance, Posture and Gait in Patients With Parkinson Disease · NA · unknown
- NCT05267223 — Experience of Rehabilitation Amongst Individuals With Paraplegia · unknown
- NCT05077787 — Tactile and Kinaesthetic Stimulation in Neonates With Hyperbilirubinaemia · NA · completed
- NCT04321655 — Reduce Pain and Improve Quality of Life in Patient With Knee Osteoarthritis by Light, Sound and Brain Stimulation · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03940339 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Asir John Samuel
- Last refreshed: 16 June 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03940339.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing